- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Breast
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
I am a Consultant Senior Lecturer in Medical Oncology at the University of Bristol and an Honorary Consultant Medical Oncologist at University Hospitals Bristol and Weston NHS Foundation Trust specialising in breast cancer. I practice in all areas of breast oncology but have a special interest in younger women with breast cancer, management of the side effects of treatment, antibody drug conjugates, including Her2 low disease, molecular testing and in triple negative breast cancer. I am passionate about improving patient care and helping patients decide the best individual treatment for them and I always spend time trying to go above and beyond for patients with appointments never shorter than 30 minutes for follow ups or 60 minutes for new patients or second opinions. I regularly give talks for Breast Cancer Now for women with breast cancer to help them understand treatment options for both metastatic breast cancer and TNBC.
I completed my medical oncology clinical and academic training in Bristol and undertook a Cancer Research UK Clinical Fellowship leading to being awarded a PhD from Cardiff University examining the role of breast cancer stem cells in chemo-resistance and exploring novel therapeutic strategies. I also undertook a postgraduate diploma in oncology from the Institute of Cancer Research University of London. I was the recipient of a Coltmans Scholar Award from the San Antonio Breast Cancer Symposium, the worlds largest breast cancer meeting, for work on the gut microbiome and breast cancer, and have multiple peer-reviewed publications. I have presented widely at national and international conferences.
I am heavily involved in clinical trials as a principal investigator in Bristol and chief investigator. This includes global chief investigator roles in 2 clinical studies for metastatic breast cancer. I am a member of national collaborative research groups and was appointed to the National Cancer Institute Breast Cancer Precision Medicine Working group in 2022 and I am member of the NICE expert panel of breast oncologists for the breast cancer guideline committee.
I strive to provide personalised care using up-to-date pragmatic evidenced-based medicine.
Areas of interest
Breast cancer; chemotherapy; immunotherapy; targeted therapy; endocrine therapy; hormone therapy; her2 low; antibody drug conjugates; younger women with breast cancer; survivorship; menopausal symptoms
Medical secretaries
- Donna Bastin
- Genesis Care Bristol 300 Park Avenue Aztec West Almondsbury Bristol BS32 4SY
- 07593 261585
- donna.bastin@bristoloncology.net
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
GenesisCare, Bristol (5-50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (1-5)
GenesisCare, Bristol (1-5)